NIH-funded research U01 cooperative agreement

Improving kidney transplants between HIV-positive patients in South Africa

Official title: Maximizing the success of HIV+ to HIV+ kidney transplantation in South Africa

Funded at University of Cape Town · NIH-10840812 · Data updated 2026-11-12

This study is looking at how well kidney transplants work for people living with HIV, especially focusing on their health and the chances of their new kidney being accepted, to help improve transplant services for those in need in South Africa.

More Kidney Transplantation research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Cape Town
NIH-funded
Lab location1 site (Rondebosch, South Africa)
Project startApril 6, 2020
Project endMarch 31, 2026
Funding year2024
Award (this year)$159,840
NIH project number5U01AI152153-05
Project IDNIH-10840812 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are HIV-positive individuals in need of a kidney transplant.

Less likely to help

Patients who are not HIV-positive or those who do not require a kidney transplant may not benefit from this research.

What this research studies

This research investigates the outcomes of kidney transplants between HIV-positive patients, focusing on patient and graft survival rates. It aims to understand how immune modulators affect the HIV latent viral reservoir, which is crucial for finding a cure for HIV. The study also examines the risk of organ rejection in these patients and seeks to enhance transplantation services in underserved areas of South Africa. By collaborating with experts in HIV and transplantation, the research aims to improve clinical practices and patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective kidney transplants for HIV-positive patients, improving their quality of life.

How similar studies have gone: Previous research has shown comparable survival rates for HIV-positive kidney transplant recipients, indicating a promising approach in this area.

Where this research is happening

  • University of Cape Town
    Rondebosch, South Africa
    Active

Researchers

  • Principal investigator: Muller, Elmi — University of Cape Town
  • Study coordinator: Muller, Elmi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.